![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/traverse-biotech-has-been-awarded-a-phase-i-sbir-grant-from-the-national-cancer-institute-to-develop-targeted-immunotherapy-for-selected-solid-tumors-301959404.html